Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 689,053
  • Shares Outstanding, K 67,422
  • Annual Sales, $ 0 K
  • Annual Income, $ -100,700 K
  • 60-Month Beta 1.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.10
Trade ORIC with:

Options Overview Details

View History
  • Implied Volatility 142.20% ( +20.09%)
  • Historical Volatility 68.32%
  • IV Percentile 81%
  • IV Rank 57.52%
  • IV High 234.44% on 10/20/23
  • IV Low 17.30% on 01/02/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 320
  • Open Int (30-Day) 277

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.40
  • Low Estimate -0.43
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +16.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.33 +61.45%
on 06/27/24
11.96 -14.55%
on 07/17/24
+3.04 (+42.34%)
since 06/18/24
3-Month
6.33 +61.45%
on 06/27/24
11.96 -14.55%
on 07/17/24
+1.03 (+11.21%)
since 04/19/24
52-Week
5.27 +93.93%
on 10/13/23
16.65 -38.62%
on 03/06/24
+2.62 (+34.47%)
since 07/19/23

Most Recent Stories

More News
Why Shares of Oric Pharmaceuticals Jumped Monday

Private investors agreed to spend $85 million to purchase the company's stock.

ORIC : 10.22 (unch)
Pre-Market Brief: Stocks Mixed As Brutal Year Nears End

March S&P 500 futures (ESH23) are trending down -0.45% this morning after three major U.S. benchmark indices ended the regular session higher, powered by a rebound in mega-cap growth stocks as U.S. unemployment...

ESH23 : 3,957.05s (-0.09%)
META : 476.79 (+0.20%)
AAPL : 224.31 (+0.06%)
SESN : 12.5760 (+7.29%)
HOTH : 0.8222 (-7.68%)
CLLS : 2.03 (-6.02%)
ORIC : 10.22 (unch)
PFE : 29.97 (+0.88%)
TGTX : 21.00 (-1.08%)
Pre-Market Brief: Stocks Mostly Lower Ahead of Key U.S. GDP Data

March S&P 500 futures (ESH23) are trending down -0.10% this morning after three major U.S. benchmark indices rallied on Wednesday, notching their biggest one-day percentage gains this month as upbeat corporate...

ESH23 : 3,957.05s (-0.09%)
NKE : 72.70 (+0.44%)
FDX : 306.31 (-0.10%)
ISO : 0.7616 (+2.78%)
MU : 114.26 (-2.72%)
LRCX : 917.11 (-3.73%)
MRTX : 58.70 (-0.17%)
ORIC : 10.22 (unch)
LXRX : 1.9900 (-4.78%)
ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company...

ORIC : 10.22 (unch)
ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

SOUTH SAN FRANCISCO and SAN DIEGO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company...

ORIC : 10.22 (unch)
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update

Three ongoing single agent Phase 1 programs, ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers, and ORIC-944 in prostate cancer, all expected to...

ORIC : 10.22 (unch)
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology...

ORIC : 10.22 (unch)
Why ORIC Pharmaceuticals Stock Is Crashing Today

The company discontinued development of its lead clinical program.

ORIC : 10.22 (unch)
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update

Announces decision to discontinue development of ORIC-101 Company will focus on advancing its three single agent Phase 1 programs, ORIC-533 in multiple...

ORIC : 10.22 (unch)
ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology...

ORIC : 10.22 (unch)

Business Summary

ORIC Pharmaceuticals Inc. is a clinical stage oncology company. It is focused on developing treatments which address mechanisms of therapeutic resistance. The company's product candidate consists of ORIC-101 and ORIC-533 which are in clinical stage. ORIC Pharmaceuticals Inc. is based in San Francisco,...

See More

Key Turning Points

3rd Resistance Point 10.72
2nd Resistance Point 10.55
1st Resistance Point 10.38
Last Price 10.22
1st Support Level 10.04
2nd Support Level 9.87
3rd Support Level 9.70

See More

52-Week High 16.65
Fibonacci 61.8% 12.30
Fibonacci 50% 10.96
Last Price 10.22
Fibonacci 38.2% 9.62
52-Week Low 5.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar